Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4788-4792

  Planas Silva, Maricarmen D ^a   Donaher, Liu ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MITOGENESIS; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL DIVISION; CELLS, CULTURED; CYCLIN D1; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0033214904     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 1arrested human breast cancer cells. Oncogene, 12: 2315-2324, 1996.
2. Foster, J. S., and Wimalasena, J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol., 10: 488-498, 1996.
3. Planas-Silva, M. D., and Weinberg, R. A. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol., 17: 4059-4069, 1997.
4. Prall, O. W. J., Sarcevic, B., Musgrove, E. A., Watts, C. K. W., and Sutherland, R. L. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem., 272: 10882-10894, 1997.
5. 1 checkpoint. Mol. Cell. Biol., 16: 6917-6925, 1996.
6. Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., and Sutherland, R. L. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol. Cell. Biol., 18: 4499-4508, 1998.
7. Wilcken, N. R. C., Prall, O. W. J., Musgrove, E. A., and Sutherland, R. L. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin. Cancer Res., 3: 849-854, 1997.
8. Touitou, I., Mathieu, M., and Rochefort, H. Stable transfection of the estrogen receptor cDNA into HeLa cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth. Biochem. Biophys. Res. Commun., 169: 109-115, 1990.
9. Zajchowski, D. A., and Sager, R. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol. Endocrinol., 5: 1613-1623, 1991.
10. Jiang, S-Y., and Jordan, V. C. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst., 84: 580-591, 1992.
11. Zajchowski, D. A., Sager, R., and Webster, L. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res., 53: 5004-5011, 1993.
12. Clarke, R. B., Howell, A., Potten, C. S., and Anderson, E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res., 57: 4987-4991, 1997.
13. Saceda, M., Lippman, M. E., Cambon, P., Lindsey, R. L., Ponglikitmongkol, M., Puente, M., and Martin, M. B. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol., 2: 1157-1162, 1988.
14. Kaneko, K. J., Furlow, J., D., and Gorski, J. Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol. Endocrinol., 7: 879-888, 1993.
15. Gehm, B. D., McAndrews, J. M., Chien, P-Y., and Jameson, J. L. Resveratrol, a polyphenolic compound found in grapes and wines, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA, 94: 14138-14143, 1997.
16. Weisz, A., and Bresciani, F. Estrogen induces expression of c-fos and myc protooncogenes in rat uterus. Mol. Endocrinol., 2: 816-824, 1988.
17. Cicatiello, L., Ambrosino, C., Coletta, B., Scalona, M., Sica, V., Bresciani, F., and Weisz, A. Transcriptional activation of jun and actin genes by estrogen during mitogenic stimulation of rat uterine cells. J. Steroid Biochem. Mol. Biol., 41: 523-528, 1992.
18. van der Burg, B., De Groot, R. P., Isbrücker, L., Kruijer, W., and De Laat, S. W. Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol., 40: 215-221, 1991.
19. Philips, A., Chalbos, D., and Rochefort, H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem., 268: 14103-14108, 1993.
20. Brown, J. R., Nigh, E., Lee, R. J., Ye, H., Thompson, M. A., Saudou, F., Pestell, R. G., and Greenberg, M. E. Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell. Biol., 18: 5609-5619, 1998.
21. Wisdom, R., Johnson, R. S., and Moore, C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J., 18: 188-197, 1999.
22. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol., 19: 330-341, 1999.
23. Hui, R., Cornish, A. L., McClelland, R. A., Robertson, J. F., Blamey, R. W., Musgrove, E. A., Nicholson, R. I., and Sutherland, R. L. Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin. Cancer Res., 2: 923-928, 1996.
24. w15 cells. Oncol. Rep., 5: 1025-1033, 1998.
25. Russo, J., Ao, X., Grill, C., and Russo, I. H. Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res. Treat., 53: 217-227, 1999.
26. Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med., 1: 1257-1260, 1995.
27. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem., 270: 23589-23597, 1995.
28. Duan, R., Porter, W., and Safe, S. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology. 139: 1981-1990, 1998.
29. Weisz, A., and Rosales, R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res., 18: 5097-5106, 1990.
30. Hyder, S. M., Chiappetta, C., and Stancel, G. M. The 3′-flanking region of the mouse c-fos gene contains a cluster of GGTCA hormone-response like elements. Mol. Biol. Rep., 25: 189-191, 1998.
31. Hyder, S. M., Nawaz, Z., Chiappetla, C., Yokoyama, K., and Stancel, G. M. The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J. Biol. Chem., 270: 8506-8513, 1995.